The TNM Staging System (Stages I–IV)
The TNM staging system is the internationally accepted standard for staging pleural mesothelioma. Developed by the American Joint Committee on Cancer (AJCC) and the International Association for the Study of Lung Cancer (IASLC), the TNM system evaluates three factors: the size and extent of the primary Tumor, whether cancer has spread to nearby lymph Nodes, and whether Metastasis (distant spread) has occurred. The current edition (AJCC 8th Edition) classifies pleural mesothelioma into four stages.
The TNM system classifies pleural mesothelioma into four stages based on how far the cancer has spread. The table below summarizes each stage. For a detailed breakdown of what each stage means for your treatment options, prognosis, and quality of life, see our in-depth Stages of Mesothelioma guide. You can also review mesothelioma statistics for survival rates by stage.
| Stage | Tumor Extent | Lymph Nodes | Metastasis | Primary Treatment |
|---|---|---|---|---|
| Stage I | Pleura only (one side) | None | None | Surgery + chemo + radiation (multimodal) |
| Stage II | Pleura + lung/diaphragm (one side) | None or ipsilateral only | None | Surgery + chemo + radiation; clinical trials |
| Stage III | Chest wall, pericardium, or extensive local invasion | Mediastinal or contralateral | None | Chemo, immunotherapy, radiation; surgery in select cases |
| Stage IV | Any extent | Any | Distant organs | Immunotherapy, chemo, palliative care, clinical trials |